Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 07.11.2024
Aldeyra Therapeutics Мультипликаторы 2011-2024 | ALDX
Мультипликаторы по годам Aldeyra Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.1 | -7.4 | -3.4 | -10.1 | -2.4 | -4.9 | -5.4 | -3.4 | -3.4 | -8.9 | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.6 | -1.1 | -1.1 | -1.1 | -2.2 | -1.8 | -1.4 | -1.6 | -1.4 | -2.5 | 3.5 | - | - |
EV (Enterprise Value) |
113 млн | 346 млн | -4.05 млн | 326 млн | 130 млн | 153 млн | 105 млн | 55.1 млн | 30.2 млн | 40.2 млн | -1.13 млн | 27.1 млн | 2.59 млн |
EBITDA per Share |
-0.72 | -1.07 | -1.04 | -1.01 | -2.08 | -1.83 | -1.41 | -1.64 | -1.39 | -1.9 | - | - | - |
EV/EBITDA |
0.7 | -9.3 | -2.1 | -3.6 | -4.5 | -2.8 | -2.4 | -5.4 | - | - | - | ||
PEG |
0.47 | 17.13 | 0.89 | -0.2 | 0.1 | 0.18 | -0.36 | 0.19 | -0.08 | 0.05 | - | - | - |
P/B |
1.9 | 3.0 | 1.0 | 6.4 | 3.1 | 2.2 | 3.0 | 2.9 | 1.7 | 7.4 | - | - | - |
P/CF |
-7.5 | -8.1 | -4.7 | -10.1 | -3.3 | -6.4 | -6.3 | -4.2 | -4.4 | -9.6 | - | - | - |
ROE % |
-31.34 | -41.07 | -28.08 | -63.11 | -126.51 | -44.90 | -56.41 | -86.37 | -48.60 | -82.55 | - | - | - |
ROA % |
-25.31 | -34.21 | -24.78 | -45.05 | -80.55 | -40.90 | -50.57 | -74.24 | -42.87 | -59.03 | - | - | - |
ROCE % |
-35.72 | -41.51 | -27.33 | -48.87 | -90.25 | -45.83 | -55.09 | -81.68 | -45.95 | -97.47 | - | - | - |
Current Ratio |
5.2 | 6.0 | 8.5 | 6.7 | 5.8 | 11.2 | 13.1 | 10.9 | 13.3 | 6.6 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Aldeyra Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.25 | -0.28 | -0.14 | - | -0.14 | -0.15 | -0.27 | - | -0.25 | -0.3 | -0.29 | - | -0.27 | -0.28 | -0.25 | - | -0.23 | -0.25 | -0.34 | - | -0.69 | -0.49 | -0.58 | - | -0.52 | -0.46 | -0.43 | - | -0.32 | -0.35 | -0.37 | - | -0.38 | -0.41 | -0.51 | - | -0.35 | -0.27 | -0.32 | - | -0.36 | -1.43 | -0.04 | - | 2.76 | -5.47 | -13.03 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.16 | - | - | - | -0.28 | - | -0.25 | -0.3 | -0.28 | - | -0.26 | -0.27 | -0.24 | - | -0.22 | -0.23 | -0.33 | - | -0.7 | -0.51 | -0.64 | - | -0.52 | -0.46 | -0.44 | - | -0.32 | -0.35 | -0.37 | - | -0.38 | -0.4 | -0.51 | - | -0.34 | -0.26 | -0.32 | - | -0.35 | -0.44 | -3.8 | - | -3.68 | -3.13 | -0.93 | - | - | - | - | - | - | - | - |
ROE % |
-48.68 | -37.57 | -27.36 | -24.95 | -33.93 | -36.24 | -39.54 | -27.99 | -35.18 | -33.40 | -29.58 | -22.54 | -37.45 | -45.17 | -51.41 | -44.13 | -83.05 | -107.07 | -122.15 | -99.13 | -111.62 | -85.18 | -67.91 | -32.63 | -45.22 | -45.33 | -48.28 | -38.85 | -60.91 | -70.38 | -76.84 | -64.87 | -78.40 | -69.87 | -58.97 | -31.09 | -63.06 | -81.51 | -90.60 | -43.64 | -66.79 | -57.96 | -35.99 | -51.72 | -51.72 | -28.57 | -32.47 | - | - | - | - | - | - | - | - |
ROA % |
-37.53 | -30.20 | -22.61 | -20.62 | -28.29 | -30.40 | -32.17 | -22.75 | -29.14 | -20.32 | -26.14 | -19.88 | -30.52 | -34.78 | -37.98 | -31.51 | -56.29 | -70.43 | -79.05 | -63.12 | -74.49 | -61.08 | -52.95 | -29.72 | -41.01 | -40.92 | -43.42 | -34.83 | -53.79 | -61.46 | -66.52 | -55.76 | -67.70 | -60.67 | -51.50 | -27.42 | -50.29 | -61.22 | -66.22 | -31.21 | 217.48 | 489.03 | 460.04 | 555.69 | 555.69 | 307.00 | 348.91 | - | - | - | - | - | - | - | - |
ROCE % |
-53.33 | -42.13 | -31.77 | -27.97 | -37.09 | -38.44 | -40.65 | -27.94 | -34.97 | -32.88 | -28.93 | -21.84 | -35.94 | -43.01 | -48.73 | -42.24 | -81.78 | -107.24 | -123.85 | -104.36 | -117.00 | -90.09 | -72.11 | -33.02 | -45.69 | -45.71 | -48.59 | -38.99 | -61.06 | -70.45 | -76.84 | -64.85 | -78.27 | -69.62 | -58.63 | -30.75 | -62.07 | -79.97 | -97.32 | -77.33 | -74.43 | -40.21 | -11.56 | 6.08 | 6.08 | 3.18 | 0.72 | - | - | - | - | - | - | - | - |
Current Ratio |
3.6 | 4.5 | 5.1 | 5.2 | 6.1 | 6.0 | 5.4 | 6.0 | 6.9 | - | 7.0 | 8.5 | 9.0 | 11.3 | 6.9 | 3.5 | 3.5 | 3.5 | 3.5 | 2.8 | 2.8 | 2.8 | 2.8 | 11.2 | 11.2 | 11.2 | 11.2 | 9.7 | 9.7 | 9.7 | 9.7 | 7.1 | 7.1 | 7.1 | 7.1 | 8.5 | 8.5 | 8.5 | 8.5 | 3.5 | 3.5 | 3.5 | 3.5 | 0.7 | 0.7 | 0.7 | 0.7 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD